1360081003: Inflammation of pituitary due to and following immunotherapy (disorder)

• SNOMED CT Concept\Clinical finding (finding)\...
• \Head finding (finding)\Finding of brain\Disorder of brain (disorder)\Disorder of pituitary gland\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Head finding (finding)\Finding of brain\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Head finding (finding)\Finding of brain\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Head finding (finding)\Disorder of head (disorder)\Inflammatory disorder of head\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Head finding (finding)\Disorder of head (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Head finding (finding)\Disorder of head (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Head finding (finding)\Disorder of head (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Central nervous system finding\Finding of brain\Disorder of brain (disorder)\Disorder of pituitary gland\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Central nervous system finding\Finding of brain\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Central nervous system finding\Finding of brain\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Central nervous system finding\Disorder of the central nervous system (disorder)\Disorder of central nervous system due to and following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Central nervous system finding\Disorder of the central nervous system (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Central nervous system finding\Disorder of the central nervous system (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Central nervous system finding\Disorder of the central nervous system (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Central nervous system finding\Disorder of the central nervous system (disorder)\Inflammatory disease of the central nervous system\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Procedure related finding\Postprocedural state finding\Disorder following clinical procedure\Disorder of nervous system following procedure (disorder)\Hypopituitarism following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Procedure related finding\Postprocedural state finding\Disorder following clinical procedure\Disorder of nervous system following procedure (disorder)\Neurological complication of procedure\Disorder of central nervous system due to and following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Procedure related finding\Complication of procedure\Neurological complication of procedure\Disorder of central nervous system due to and following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Procedure related finding\Complication of procedure\Endocrine system complication of procedure\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Drug action\Effects of immunotherapy\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Inflammation of specific body systems\Inflammatory disease of the central nervous system\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of endocrine system\Disorder of pituitary gland\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of endocrine system\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of endocrine system\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of endocrine system\Endocrine system complication of procedure\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of nervous system (disorder)\Disorder of nervous system following procedure (disorder)\Hypopituitarism following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of nervous system (disorder)\Disorder of nervous system following procedure (disorder)\Neurological complication of procedure\Disorder of central nervous system due to and following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of nervous system (disorder)\Disorder of the central nervous system (disorder)\Disorder of central nervous system due to and following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of nervous system (disorder)\Disorder of the central nervous system (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of nervous system (disorder)\Disorder of the central nervous system (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of nervous system (disorder)\Disorder of the central nervous system (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of body system\Disorder of nervous system (disorder)\Disorder of the central nervous system (disorder)\Inflammatory disease of the central nervous system\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder following clinical procedure\Disorder of nervous system following procedure (disorder)\Hypopituitarism following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder following clinical procedure\Disorder of nervous system following procedure (disorder)\Neurological complication of procedure\Disorder of central nervous system due to and following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Inflammatory disorder\Inflammation of specific body structures or tissue\Inflammatory disorder of head\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Inflammatory disorder\Inflammation of specific body structures or tissue\Inflammation of specific body systems\Inflammatory disease of the central nervous system\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Inflammatory disorder\Inflammation of specific body structures or tissue\Inflammation of specific body organs\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of head (disorder)\Inflammatory disorder of head\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of head (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypophysitis\Inflammation of pituitary caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of head (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism caused by drug (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Disorder of head (disorder)\Disorder of brain (disorder)\Disorder of pituitary gland\Hypopituitarism\Hypopituitarism following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Complication of procedure\Neurological complication of procedure\Disorder of central nervous system due to and following procedure (disorder)\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.
• \Disease\Complication of procedure\Endocrine system complication of procedure\A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Mar 2025. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5439662012	A rare, acquired pituitary hormone deficiency characterised by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.	en	Definition	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
5439663019	A rare, acquired pituitary hormone deficiency characterized by inflammation of the pituitary gland secondary to immunotherapy for cancer treatments (such as monoclonal antibodies against cytotoxic T lymphocytes antigen, programmed cell death protein-1, and programmed cell death ligand molecules). Major clinical features include headache, fatigue, adrenal insufficiency and hypothyroidism. Patients may also have nausea and vomiting associated to the headache as well as dizziness and hot flashes. Enlargement of the pituitary gland is present in the brain imaging.	en	Definition	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
5439660016	Inflammation of pituitary due to and following immunotherapy (disorder)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5439661017	Immunotherapy induced hypophysitis	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5439666010	Inflammation of pituitary due to and following immunotherapy	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

Reference Sets

Component annotation with string value reference set (foundation metadata concept)

Back to Start